FDA to Mandate Placebo-Controlled Trials for New Vaccines

The US Food and Drug Administration will require all new vaccines to undergo placebo-controlled trials before approval — a policy shift that could reshape how immunizations are developed.

The change will bring “radical transparency to the American public,” said Andrew Nixon, a spokesman for the Department of Health and Human Services, in an email to Bloomberg.